Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
2.
PLoS One ; 9(12): e114486, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25521205

RESUMO

BACKGROUND: Genetic variants within the major histocompatibility complex (MHC) represent the strongest genetic susceptibility factors for primary sclerosing cholangitis (PSC). Identifying the causal variants within this genetic complex represents a major challenge due to strong linkage disequilibrium and an overall high physical density of candidate variants. We aimed to refine the MHC association in a geographically restricted PSC patient panel. METHODOLOGY/PRINCIPAL FINDINGS: A total of 365 PSC cases and 368 healthy controls of Scandinavian ancestry were included in the study. We incorporated data from HLA typing (HLA-A, -B, -C, -DRB3, -DRB1, -DQB1) and single nucleotide polymorphisms across the MHC (n = 18,644; genotyped and imputed) alongside previously suggested PSC risk determinants in the MHC, i.e. amino acid variation of DRß, a MICA microsatellite polymorphism and HLA-C and HLA-B according to their ligand properties for killer immunoglobulin-like receptors. Breakdowns of the association signal by unconditional and conditional logistic regression analyses demarcated multiple PSC associated MHC haplotypes, and for eight of these classical HLA class I and II alleles represented the strongest association. A novel independent risk locus was detected near NOTCH4 in the HLA class III region, tagged by rs116212904 (odds ratio [95% confidence interval] = 2.32 [1.80, 3.00], P = 1.35×10-11). CONCLUSIONS/SIGNIFICANCE: Our study shows that classical HLA class I and II alleles, predominantly at HLA-B and HLA-DRB1, are the main risk factors for PSC in the MHC. In addition, the present assessments demonstrated for the first time an association near NOTCH4 in the HLA class III region.


Assuntos
Colangite Esclerosante/genética , Antígenos HLA-B/genética , Cadeias HLA-DRB1/genética , Polimorfismo de Nucleotídeo Único , Estudos de Casos e Controles , Humanos , Proteínas Proto-Oncogênicas/genética , Receptor Notch4 , Receptores Notch/genética , Países Escandinavos e Nórdicos
3.
Curr Biol ; 24(21): 2518-25, 2014 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-25447991

RESUMO

BACKGROUND: Rapa Nui (Easter Island), located in the easternmost corner of the Polynesian Triangle, is one of the most isolated locations on the planet inhabited by humans. Archaeological and genetic evidence suggests that the island was first colonized by Polynesians around AD 1200, during their eastward expansion. Although it remains contentious whether Polynesians reached South America, suggestive evidence has been brought forward supporting the possibility of Native American contact prior to the European "discovery" of the island in AD 1722. RESULTS: We generated genome-wide data for 27 Rapanui. We found a mostly Polynesian ancestry among Rapanui and detected genome-wide patterns consistent with Native American and European admixture. By considering the distribution of local ancestry tracts of eight unrelated Rapanui, we found statistical support for Native American admixture dating to AD 1280-1495 and European admixture dating to AD 1850-1895. CONCLUSIONS: These genetic results can be explained by one or more pre-European trans-Pacific contacts.


Assuntos
Indígenas Norte-Americanos/genética , Havaiano Nativo ou Outro Ilhéu do Pacífico/genética , Migração Humana , Humanos , Polinésia/etnologia
4.
Clin Transpl ; : 167-73, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-25095505

RESUMO

In this article, we first present four significant cases where human leukocyte antigen (HLA) studies have been useful for the reconstruction of human peopling history on the worldwide scale; i.e., the spread of modern humans from East Africa, the colonization of East Asia along two geographic routes, the co-evolution of genes and languages in Africa, and the peopling of Europe through a main northward migration. These examples show that natural selection did not erase the genetic signatures of our past migrations in the HLA genetic diversity patterns observed today. In the second part, we summarize our studies on Easter Island. Using genomic HLA typing, we could trace an introduction of HLA alleles of native American (Amerindian) origin to Easter Island before the Peruvian slave trades; i.e., before the 1860s, and provide suggestive evidence that they may have already been introduced in prehistoric time. Our results give further support to an initial Polynesian population of the island, but also reveal an early contribution by Amerindians. Together, our data illustrate the usefulness of typing for HLA alleles to complement genetic analyses in anthropological investigations.


Assuntos
Antropologia , Antígenos HLA/genética , Migração Humana , Cromossomos Humanos Y/genética , DNA Mitocondrial/genética , Ásia Oriental , Frequência do Gene , Variação Genética , Teste de Histocompatibilidade , Humanos , Polimorfismo Genético , Polinésia
5.
Philos Trans R Soc Lond B Biol Sci ; 367(1590): 812-9, 2012 Mar 19.
Artigo em Inglês | MEDLINE | ID: mdl-22312048

RESUMO

It is now generally accepted that Polynesia was first settled by peoples from southeast Asia. An alternative that eastern parts of Polynesia were first inhabited by Amerindians has found little support. There are, however, many indications of a 'prehistoric' (i.e. before Polynesia was discovered by Europeans) contact between Polynesia and the Americas, but genetic evidence of a prehistoric Amerindian contribution to the Polynesian gene pool has been lacking. We recently carried out genomic HLA (human leucocyte antigen) typing as well as typing for mitochondrial DNA (mtDNA) and Y chromosome markers of blood samples collected in 1971 and 2008 from reputedly non-admixed Easter Islanders. All individuals carried HLA alleles and mtDNA types previously found in Polynesia, and most of the males carried Y chromosome markers of Polynesian origin (a few had European Y chromosome markers), further supporting an initial Polynesian population on Easter Island. The HLA investigations revealed, however, that some individuals also carried HLA alleles which have previously almost only been found in Amerindians. We could trace the introduction of these Amerindian alleles to before the Peruvian slave trades, i.e. before the 1860s, and provide suggestive evidence that they were introduced already in prehistoric time. Our results demonstrate an early Amerindian contribution to the Polynesian gene pool on Easter Island, and illustrate the usefulness of typing for immunogenetic markers such as HLA to complement mtDNA and Y chromosome analyses in anthropological investigations.


Assuntos
Emigração e Imigração/história , Pool Gênico , Genética Populacional/métodos , Indígenas Sul-Americanos/genética , Havaiano Nativo ou Outro Ilhéu do Pacífico/genética , Cromossomos Humanos Y/genética , DNA Mitocondrial/genética , Genótipo , Antígenos HLA/genética , Haplótipos/genética , História Antiga , Humanos , Masculino , Linhagem , Polinésia
6.
Immunology ; 133(2): 143-64, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21480890

RESUMO

The genes coding for the main molecules involved in the human immune system--immunoglobulins, human leucocyte antigen (HLA) molecules and killer-cell immunoglobulin-like receptors (KIR)--exhibit a very high level of polymorphism that reveals remarkable frequency variation in human populations. 'Genetic marker' (GM) allotypes located in the constant domains of IgG antibodies have been studied for over 40 years through serological typing, leading to the identification of a variety of GM haplotypes whose frequencies vary sharply from one geographic region to another. An impressive diversity of HLA alleles, which results in amino acid substitutions located in the antigen-binding region of HLA molecules, also varies greatly among populations. The KIR differ between individuals according to both gene content and allelic variation, and also display considerable population diversity. Whereas the molecular evolution of these polymorphisms has most likely been subject to natural selection, principally driven by host-pathogen interactions, their patterns of genetic variation worldwide show significant signals of human geographic expansion, demographic history and cultural diversification. As current developments in population genetic analysis and computer simulation improve our ability to discriminate among different--either stochastic or deterministic--forces acting on the genetic evolution of human populations, the study of these systems shows great promise for investigating both the peopling history of modern humans in the time since their common origin and human adaptation to past environmental (e.g. pathogenic) changes. Therefore, in addition to mitochondrial DNA, Y-chromosome, microsatellites, single nucleotide polymorphisms and other markers, immunogenetic polymorphisms represent essential and complementary tools for anthropological studies.


Assuntos
Antropologia/métodos , Imunogenética , Variação Genética , Antígenos HLA/genética , Humanos , Polimorfismo Genético
8.
Ann Neurol ; 65(6): 658-66, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19630074

RESUMO

OBJECTIVE: Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system. A human leukocyte antigen (HLA) class II association is well established (DRB1*1501-DQB1*0602), but more recently HLA class II-independent associations with HLA class I variants have also been reported. The HLA class I (HLA-A, -B, -C) molecules serve as ligands for both T-cell receptors and killer immunoglobulin-like receptors (KIRs). We investigated the HLA class I alleles defined by their KIR binding motifs and the KIR genes to evaluate whether these genes could influence MS susceptibility or severity, alone or in combination. METHODS: We typed Norwegian MS patients (n = 631) and controls (n = 555) for HLA-A, -B, -C and -DRB1 alleles as well as the presence or absence of genes encoding inhibitory (KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL5, KIR3DL1, KIR3DL2, KIR3DL3) and activating (KIR2DS1, KIR2DS2, KIR2DS3, KIR2DL4, KIR2DS4, KIR2DS5, KIR3DS1) KIRs. RESULTS: The frequency of the HLA-Bw4 specificity, which is the ligand for the inhibitory KIR3DL1, was significantly reduced in MS patients as compared with controls (41.4% vs 55.1%, p(uncorrected (uc)) = 4.6 x 10(-6)). Also after stratifying for known HLA class II associations, the HLA-Bw4 association was seen (p(uc) = 0.002). No significant differences in gene carrier frequencies of inhibitory and activating KIRs were observed. However, our data indicate that MS patients who carry the activating KIR2DS2 and the inhibitory KIR2DL2 genes have more severe disease than patients not carrying these genes. INTERPRETATION: Carriage of the ligand of the inhibitory KIR3DL1 receptor, HLA-Bw4, was found to protect against MS in an HLA-DRB1 independent manner.


Assuntos
Antígenos HLA-B/fisiologia , Esclerose Múltipla/imunologia , Esclerose Múltipla/prevenção & controle , Receptores KIR/metabolismo , Adolescente , Adulto , Criança , Feminino , Triagem de Portadores Genéticos , Antígenos HLA-B/genética , Antígenos HLA-B/metabolismo , Antígenos HLA-DR/fisiologia , Cadeias HLA-DRB1 , Humanos , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/metabolismo , Ligação Proteica/imunologia , Receptores KIR/genética , Receptores KIR/fisiologia , Adulto Jovem
9.
Hepatology ; 47(1): 90-6, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18023027

RESUMO

UNLABELLED: Primary sclerosing cholangitis (PSC) is often complicated by the development of cholangiocarcinoma (CCA). Genetic variation of natural killer cell receptor G2D (NKG2D) has been associated with cancer susceptibility. An important ligand for NKG2D, major histocompatibility complex class I chain-related molecule A (MICA), serves as a marker of cellular stress. The 5.1 allele of the gene encoding MICA has been associated with PSC. In this study, we aimed to investigate the influence of genetic variations in the NKG2D-MICA receptor-ligand pair on the risk of CCA in patients with PSC. Seven single nucleotide polymorphisms (SNPs) covering the NKG2D gene were genotyped in 365 Scandinavian PSC patients and 368 healthy controls with TaqMan technology. Genotype data on the MICA 5.1 variant were available from previous studies. Forty-nine of the PSC patients (13.6%) had developed CCA at the time of study. Two of the NKG2D SNPs were associated with an increased risk of CCA: rs11053781 [odds ratio (OR) = 2.08, 95% confidence interval (CI) = 1.31-3.29, corrected P (P(c)) = 0.011] and rs2617167 (OR = 2.32, 95% CI = 1.47-3.66, P(c) = 0.0020). Carriership of the MICA 5.1 allele was associated with resistance against CCA (OR = 0.43, 95% CI = 0.20-0.95, not corrected P = 0.032). CONCLUSION: Our results show that genetic variants of the NKG2D receptor are associated with development of CCA in PSC patients. This suggests that interaction between NKG2D and MICA is involved in protection against CCA in PSC. Patients who are homozygous for the nonrisk alleles are unlikely to develop CCA; this finding could be helpful in identifying PSC patients with a low CCA risk.


Assuntos
Neoplasias dos Ductos Biliares/genética , Ductos Biliares Intra-Hepáticos , Colangiocarcinoma/genética , Colangite Esclerosante/complicações , Antígenos de Histocompatibilidade Classe I/genética , Receptores Imunológicos/genética , Adolescente , Adulto , Idoso , Alelos , Neoplasias dos Ductos Biliares/etiologia , Estudos de Casos e Controles , Criança , Colangiocarcinoma/etiologia , Predisposição Genética para Doença , Humanos , Pessoa de Meia-Idade , Subfamília K de Receptores Semelhantes a Lectina de Células NK , Polimorfismo de Nucleotídeo Único , Receptores de Células Matadoras Naturais
10.
Hum Immunol ; 68(9): 748-55, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17869649

RESUMO

Type 1 diabetes (T1D) is an autoimmune disease characterized by loss of beta cells in the pancreas. The CTSL2 gene encodes the cysteine protease cathepsin V involved in antigen presentation in human cortical thymic epithelial cells, and involvement of the protease in autoimmunity has been suggested. This study aimed to evaluate CTSL2 as a candidate gene for T1D, and test whether the gene predisposes more generally to autoimmune diseases. Four polymorphisms aiming at tagging the CTSL2 locus were genotyped in 421 T1D families, and subsequently in 861 rheumatoid arthritis patients, 530 juvenile idiopathic arthritis patients, and 559 controls of Norwegian origin. Additionally, DNA from 83 German myasthenia gravis (MG) patients and 244 controls were investigated. A polymorphism, rs16919034, situated downstream of CTSL2 was associated with T1D (60.8%T, p = 0.008; p(c) = 0.03). An association with early-onset MG (45% in cases vs 36.6% in controls; p = 0.03) was observed for another polymorphism (rs4361859) situated upstream of the gene, but within the same linkage disequilibrium block. No association was observed in rheumatoid arthritis or juvenile idiopathic arthritis. Our findings suggest that the CTSL2 gene is associated with T1D and with early-onset MG.


Assuntos
Catepsinas/genética , Cisteína Endopeptidases/genética , Diabetes Mellitus Tipo 1/genética , Predisposição Genética para Doença , Miastenia Gravis/genética , Polimorfismo de Nucleotídeo Único , Adolescente , Adulto , Idade de Início , Catepsina L , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Desequilíbrio de Ligação , Masculino , Miastenia Gravis/epidemiologia
11.
BMC Med Genet ; 8: 33, 2007 Jun 12.
Artigo em Inglês | MEDLINE | ID: mdl-17565662

RESUMO

BACKGROUND: The chemokine receptor CCR5 has been detected at elevated levels on synovial T cells, and a 32 bp deletion in the CCR5 gene leads to a non-functional receptor. A negative association between the CCR5Delta32 and rheumatoid arthritis (RA) has been reported, although with conflicting results. In juvenile idiopathic arthritis (JIA), an association with CCR5 was recently reported. The purpose of this study was to investigate if the CCR5Delta32 polymorphism is associated with RA or JIA in Norwegian cohorts. METHODS: 853 RA patients, 524 JIA patients and 658 controls were genotyped for the CCR5Delta32 polymorphism. RESULTS: The CCR5Delta32 allele frequency was 11.5% in the controls vs. 10.4% in RA patients (OR = 0.90; P = 0.36) and 9.7% in JIA patients (OR = 0.85; P = 0.20). No decreased homozygosity was observed for CCR5Delta32, as previously suggested. CONCLUSION: Our data do not support an association between the CCR5Delta32 allele and Norwegian RA or JIA patients. Combining our results with those from a recently published meta-analysis still provide evidence for a role for CCR5Delta32 in RA, albeit substantially weaker than the effect first reported.


Assuntos
Artrite Juvenil/genética , Artrite Reumatoide/genética , Polimorfismo Genético , Receptores CCR5/genética , Alelos , Estudos de Casos e Controles , Frequência do Gene , Genótipo , Humanos , Noruega
12.
Hum Immunol ; 68(7): 592-8, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17584581

RESUMO

We have previously mapped a separate type 1 diabetes (T1D) association in the extended MHC class I region, marked by D6S2223, on the DRB1*03-DQA1*0501-DQB1*0201 haplotype. The associated region encompasses a gene encoding a thymus-specific serine protease (PRSS16), presumably involved in positive selection of T cells or in T-cell regulation. Fourteen PRSS16 polymorphisms were genotyped in two steps using a total of six T1D family data sets, as well as case-control materials for both T1D and celiac disease (CD). An association with a 15 base-pair deletion in exon 12 of PRSS16 was found on the DRB1*03-DQA1*0501-DQB1*0201 haplotype for both T1D and CD, but it could not explain the more pronounced disease associations observed at marker D6S2223. We compared the performance of the 14 tested PRSS16 polymorphisms, selected after our previous comprehensive screen, against HapMap selected tag SNPs. Use of a HapMap based SNP selection strategy would result in loss of a large proportion of the genetic variation in PRSS16. Our data suggest that it is unlikely that polymorphisms within the PRSS16 gene are involved in the predisposition to T1D. However, we cannot rule out that regulatory polymorphisms located some distance away from the gene may be involved.


Assuntos
Diabetes Mellitus Tipo 1/genética , Haplótipos , Polimorfismo de Nucleotídeo Único , Serina Endopeptidases/genética , Estudos de Casos e Controles , Diabetes Mellitus Tipo 1/enzimologia , Feminino , Genes MHC Classe I , Predisposição Genética para Doença , Humanos , Masculino , Dados de Sequência Molecular , Fatores de Risco , Timo/enzimologia
13.
J Hepatol ; 46(5): 899-906, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17383044

RESUMO

BACKGROUND/AIMS: Combinations of killer immunoglobulin-like receptors (KIRs) and HLA class I ligands that reduce natural killer (NK) cell inhibition have been shown to increase risk for autoimmune diseases. We aimed to clarify to what extent such combinations influence susceptibility to primary sclerosing cholangitis (PSC). METHODS: Three hundred and sixty-five Scandinavian PSC patients and 368 healthy controls were genotyped for the presence or absence of genes encoding all KIRs using a PCR-SSP approach. KIR binding site variation of HLA-A, -B and -C was also determined. RESULTS: The KIR gene frequencies were similar among patients and controls. However, the frequency of HLA-Bw4 and -C2, which are ligands for the inhibitory KIRs 3DL1 and 2DL1, respectively, was significantly reduced in PSC patients as compared with controls (38.2% vs. 54.7%, P(corrected)[P(c)]=0.0006 and 42.7% vs. 56.9%, P(c)=0.009, respectively). Two HLA risk haplotypes in PSC (carrying DRB1*0301 or DRB1*1501, respectively) were devoid of both of these alleles, and carried the 5.1 variant of the major histocompatibility complex class I chain-related A (MICA) gene previously reported to influence PSC susceptibility. CONCLUSIONS: Particular variants of ligands for NK cell receptors encoded at three neighbouring genes in the HLA complex may contribute to PSC associations observed in this genetic region.


Assuntos
Colangite Esclerosante/genética , Frequência do Gene , Antígenos HLA-A/genética , Antígenos HLA-B/genética , Células Matadoras Naturais/metabolismo , Polimorfismo Genético , Receptores Imunológicos/genética , Adolescente , Adulto , Idoso , Doenças Autoimunes , Criança , Colangite Esclerosante/diagnóstico por imagem , Colangite Esclerosante/imunologia , Predisposição Genética para Doença , Antígeno HLA-B7/genética , Antígeno HLA-B8/genética , Antígenos HLA-C/genética , Antígeno HLA-DR3/genética , Antígeno HLA-DR6/genética , Cadeias HLA-DRB1 , Haplótipos/genética , Humanos , Ligantes , Desequilíbrio de Ligação , Pessoa de Meia-Idade , Noruega , Radiografia , Receptores KIR , Receptores KIR2DL1 , Receptores KIR3DL1
14.
Am J Gastroenterol ; 102(1): 115-21, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17100974

RESUMO

OBJECTIVES: Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have concurrent inflammatory bowel disease (IBD). The majority have ulcerative colitis, but there is also an association with Crohn's colitis. The pathogenetic link between PSC and IBD is unknown. We aimed to assess whether genetic risk factors in PSC can be identified on the basis of known IBD susceptibility genes and the shared PSC-IBD phenotype. METHODS: IBD-associated polymorphisms in the CARD15, TLR-4, CARD4, SLC22A4, SLC22A5, DLG5, and MDR1 genes were genotyped in a large cohort of 365 Scandinavian PSC patients and 368 healthy controls using TaqMan technology. RESULTS: No significant association between any of the investigated genetic IBD risk variants and overall susceptibility to PSC was observed. Apart from a tendency toward an increased carrier frequency of the mutant CARD15 alleles in PSC patients with concurrent Crohn's disease as compared with healthy controls (15.6%vs 9.0%, P = 0.22), no association with any of the polymorphisms investigated was evident even when considering only PSC patients with concurrent IBD. CONCLUSION: It seems unlikely that IBD-associated polymorphisms in the CARD15, TLR-4, CARD4, SLC22A4, SLC22A5, DLG5, and MDR1 genes confer susceptibility to PSC. The current knowledge of genetic risk factors in IBD may not contribute to our understanding of molecular mechanisms involved in the pathogenesis of PSC or the IBD phenotype in PSC.


Assuntos
Colangite Esclerosante/genética , Predisposição Genética para Doença , Doenças Inflamatórias Intestinais/genética , Polimorfismo Genético , Adolescente , Adulto , Idoso , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Criança , Colangite Esclerosante/epidemiologia , Feminino , Frequência do Gene , Genótipo , Haplótipos , Humanos , Doenças Inflamatórias Intestinais/epidemiologia , Masculino , Pessoa de Meia-Idade , Fenótipo , Países Escandinavos e Nórdicos/epidemiologia
15.
Tidsskr Nor Laegeforen ; 126(24): 3305-10, 2006 Dec 14.
Artigo em Norueguês | MEDLINE | ID: mdl-17170794

RESUMO

2006 marks the 50th anniversary of the first clinical organ transplantation performed in Norway and in the Nordic countries. In 1956, just two years after the first successful clinical renal transplantation had been performed between two monozygotic twins in Boston, USA; professor Leif Efskind and his team at Rikshospitalet transplanted a kidney from an unrelated donor to a patient in end stage renal disease. The patient lived for 30 days with his new kidney, which is quite impressive given the very insufficient immunosuppressive therapy available at that time. Norway has in many ways been an international forerunner in the field of transplantation. Some of the reasons behind the success are competent and enthusiastic pioneers who were active researchers within the field, early establishment of cooperation across specialities and hospitals all over the country and centralisation of this highly specialised form of medicine to one hospital.


Assuntos
Transplante de Órgãos/história , Teste de Histocompatibilidade/história , História do Século XX , Humanos , Transplante de Rim/história , Noruega , Médicos/história , Transplante de Células-Tronco/história
16.
Gastroenterology ; 131(3): 781-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16952547

RESUMO

BACKGROUND & AIMS: The steroid and xenobiotic receptor (SXR) is a ligand-dependent transcription factor that mediates protection against bile acid-induced liver injury in cholestatic animal models. Ursodeoxycholic acid and rifampicin are known ligands. We investigated whether functional polymorphisms of the SXR gene influence disease susceptibility or disease progression in patients with primary sclerosing cholangitis (PSC). METHODS: Polymorphisms at 8 loci across the SXR gene were genotyped in 327 Scandinavian PSC patients and 275 healthy controls. Kaplan-Meier survival analyses and Cox regressions were performed to estimate effects from genotypes on patient survival, defined as time from diagnostic cholangiography to death or liver transplantation. RESULTS: Susceptibility to PSC was not associated with any of the SXR polymorphisms studied. Median survival was significantly reduced in patients homozygous for the minor allele as compared with patients carrying at least 1 major allele of the neighboring polymorphisms rs6785049 (10.8 vs 14.0 years, respectively, P = .01), rs1054190 (3.6 vs 13.6 years, respectively, P = .004), and rs3814058 (3.5 vs 13.3 years, respectively, P = .01). The increased risk of death or liver transplantation was confirmed in univariate Cox regressions (relative risk [RR](rs6785049) = 1.7, 95% CI: 1.1-2.6; RR(rs1054190) = 3.1, 95% CI: 1.4-7.1; and RR(rs3814058) = 2.2, 95% CI: 1.2-4.2 for the 3 polymorphisms, respectively). In multiple Cox regressions including age at PSC onset, rs1054190 remained an independent risk factor. CONCLUSIONS: Functional SXR gene variants appear to modify disease course in PSC. Further investigations of polymorphisms in the SXR gene may provide insight into the prognostic importance of SXR-regulated pathways in this disease, perhaps even in a therapeutic perspective.


Assuntos
Colangite Esclerosante/genética , Colangite Esclerosante/mortalidade , Polimorfismo Genético , Receptores de Esteroides/genética , Adolescente , Adulto , Idoso , Criança , Colangite Esclerosante/metabolismo , Feminino , Seguimentos , Frequência do Gene , Predisposição Genética para Doença , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Receptor de Pregnano X , Prognóstico , Modelos de Riscos Proporcionais , Fatores de Risco , Taxa de Sobrevida/tendências , Fatores de Tempo , Xenobióticos
17.
Xenotransplantation ; 13(3): 215-23, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16756564

RESUMO

BACKGROUND: Complement-activating naturally occurring anti-porcine endothelial cell antibodies (Abs) are responsible for hyperacute rejection in porcine-to-primate transplantation, whereas the role of complement in acute vascular rejection, characterized by type II endothelial cell activation, is less well understood. We previously demonstrated a correlation between porcine type II endothelial cell activation, as detected by E-selectin expression, and human immunoglobulin (Ig)G3 anti-Gal alpha1-3Gal (Gal) Abs, which was not seen for IgG1, IgG2 or IgG4. The present study was undertaken to investigate whether there is a causal relationship between human anti-porcine IgG3 Abs and porcine endothelial cell activation. METHODS: IgG3 was isolated employing a Protein A column to 98.3% purity. Porcine endothelial cells were incubated with isolated human IgG3 or the combination of IgG1, IgG2 and IgG4. E-selectin expression and complement activation were investigated by flow cytometry and Western blotting, respectively. RESULTS: Purified IgG3, in contrast to the other IgG subclasses, induced a substantial increase in E-selectin expression. This activation was accompanied by complement activation as detected by C3 cleavage, and was abolished by heat inactivation or by adding the complement inhibitor FUT-175. Depletion of anti-Gal Abs reduced E-selectin expression by 60%, consistent with the presence of complement-activating anti-porcine non-Gal Abs of the IgG3 subclass. CONCLUSIONS: Collectively, these data strengthen the hypothesis that human anti-porcine endothelial cell Abs of the IgG3 subclass are essential for endothelial cell activation in porcine-to-human species grafts and demonstrate such activation to be partly independent of Gal epitopes.


Assuntos
Ativação do Complemento/imunologia , Endotélio Vascular/fisiologia , Imunoglobulina G/imunologia , Animais , Aorta , Benzamidinas , Técnicas de Cultura de Células , Inativadores do Complemento/farmacologia , Dissacarídeos/imunologia , Selectina E/efeitos dos fármacos , Selectina E/genética , Endotélio Vascular/citologia , Endotélio Vascular/imunologia , Endotélio Vascular/transplante , Ensaio de Imunoadsorção Enzimática , Citometria de Fluxo , Rejeição de Enxerto/prevenção & controle , Guanidinas/farmacologia , Cobaias , Humanos , Imunoglobulina G/classificação , Imunoglobulina G/isolamento & purificação , Primatas , Proteína Estafilocócica A , Suínos , Transplante Heterólogo/fisiologia
18.
J Hepatol ; 45(5): 704-10, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16750586

RESUMO

BACKGROUND/AIMS: Mucosal addressin cellular adhesion molecule-1 (MAdCAM-1) has been implicated in the aberrant homing of intestinal lymphocytes to the liver in primary sclerosing cholangitis (PSC). Intercellular adhesion molecule-1 (ICAM-1) has also been implicated in the pathogenesis of PSC and the E/E genotype of the K469E polymorphism has been reported to be associated with PSC susceptibility. The aims of this study were to determine if MAdCAM-1 polymorphisms or the K469E polymorphism of ICAM-1 are associated with PSC in Scandinavia. METHODS: Seven single nucleotide polymorphisms (SNPs) in MAdCAM-1 and the G421R and K469E ICAM-1 SNPs were genotyped in 365 PSC patients from Norway and Sweden. 327 Norwegian ulcerative colitis (UC) patients and 368 Norwegian bone marrow donors served as controls. RESULTS: No significant association with PSC was found for any of the MAdCAM-1 or ICAM-1 SNPs. Allele frequencies for these polymorphisms were not significantly different between PSC patients with UC, UC patients and healthy controls. CONCLUSIONS: Polymorphisms in MAdCAM-1 are not likely to significantly affect PSC susceptibility. In addition, the E/E genotype of the K469E in ICAM-1 does not influence PSC susceptibility in Scandinavia.


Assuntos
Colangite Esclerosante/genética , Imunoglobulinas/genética , Molécula 1 de Adesão Intercelular/genética , Mucoproteínas/genética , Polimorfismo de Nucleotídeo Único/genética , Estudos de Casos e Controles , Moléculas de Adesão Celular , Colangite Esclerosante/imunologia , Predisposição Genética para Doença , Humanos , Doenças Inflamatórias Intestinais , Desequilíbrio de Ligação , Dados de Sequência Molecular , Noruega , Razão de Chances , Suécia
19.
Curr Opin Immunol ; 17(5): 526-31, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16054351

RESUMO

Autoimmune diseases, such as type 1 diabetes, rheumatoid arthritis, psoriasis and systemic lupus erythematosus, affect approximately 4% of the population in industrialized countries, and are characterized by an immune-mediated destruction of autologous cells and/or tissues. More knowledge is needed to prevent and treat this large group of diseases. Unravelling the genetic predisposing factors is important in this respect, and large research efforts have been initiated to reach this goal. The human MHC, also called the human leukocyte antigen (HLA) complex, is known to harbour major genetic determinants for autoimmune diseases. For several autoimmune diseases certain classical HLA class II and/or class I genes are strongly associated with disease. As a result of recent systematic screening studies additional genes and regions in the MHC, including the extended MHC, are now known to contribute to the predisposition.


Assuntos
Doenças Autoimunes/genética , Predisposição Genética para Doença , Complexo Principal de Histocompatibilidade/genética , Antígenos de Histocompatibilidade/genética , Antígenos de Histocompatibilidade/imunologia , Humanos
20.
J Neuroimmunol ; 166(1-2): 197-201, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16005527

RESUMO

Chromosome region 2q33 encodes several regulators of the immune system, among these the CD28, CTLA4, and ICOS molecules. Involvement of these genes in multiple sclerosis (MS) is not yet clear. We investigated six microsatellites and three SNPs in a relatively large and clinically well characterised Norwegian MS cohort. No associations were observed for any of the markers analysed in 575 MS patients and 551 controls. Associations were neither found when stratifying the material for the HLA-DRB1*1501, DQB1*0602 haplotype, gender, age at onset, disease course nor familial aggregation. In conclusion, this study could not confirm association with the CD28/CTLA4/ICOS gene region.


Assuntos
Antígenos de Diferenciação de Linfócitos T/genética , Antígenos de Diferenciação/genética , Antígenos CD28/genética , Esclerose Múltipla/genética , Esclerose Múltipla/imunologia , Adolescente , Adulto , Antígenos CD , Antígeno CTLA-4 , Estudos de Casos e Controles , Criança , Estudos de Coortes , Feminino , Genótipo , Antígenos HLA-DQ/genética , Cadeias beta de HLA-DQ , Antígenos HLA-DR/genética , Cadeias HLA-DRB1 , Haplótipos , Humanos , Proteína Coestimuladora de Linfócitos T Induzíveis , Masculino , Glicoproteínas de Membrana/genética , Repetições de Microssatélites , Pessoa de Meia-Idade , Noruega , Polimorfismo de Nucleotídeo Único
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...